Cargando…

Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Detalles Bibliográficos
Autores principales:	Kinoshita, Shigeru, Ueta, Mayumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727528/ https://www.ncbi.nlm.nih.gov/pubmed/35004789 http://dx.doi.org/10.3389/fmed.2021.811570

Ejemplares similares

Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Sotozono, Chie, et al.
Publicado: (2021)

Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Ueta, Mayumi
Publicado: (2021)

Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Dobry, Allison S., et al.
Publicado: (2022)

Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Saito, Kosuke, et al.
Publicado: (2016)

Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis
por: Kinoshita, Fumie, et al.
Publicado: (2021)

Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Tsukagoshi, Eri, et al.
Publicado: (2021)

Toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Harr, Thomas, et al.
Publicado: (2010)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
por: Klimas, Natasha, et al.
Publicado: (2015)

Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis
por: Yoshikawa, Yamato, et al.
Publicado: (2020)

Recent Dermatological Treatments for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan
por: Hsieh, Ming-Hsiu, et al.
Publicado: (2021)

Human leukocyte antigen B*0702 is protective against ocular Stevens–Johnson syndrome/toxic epidermal necrolysis in the UK population
por: Butt, Gibran F., et al.
Publicado: (2021)

Cold medicine-related Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications–phenotypes and genetic predispositions
por: Ueta, Mayumi
Publicado: (2016)

Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis
por: Yan, Qingzi, et al.
Publicado: (2023)

In Silico Risk Assessment of HLA-A*02:06-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Caused by Cold Medicine Ingredients
por: Isogai, Hideto, et al.
Publicado: (2013)

Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis
por: Hasegawa, Akito, et al.
Publicado: (2020)

Ampicillin/sulbactam: Stevens-Johnson syndrome/toxic epidermal necrolysis
Publicado: (2021)

Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
por: Vivar, Karina L., et al.
Publicado: (2017)

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
por: Yang, Shang-Chen, et al.
Publicado: (2018)

Recurrent Steven-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome
por: Toledo-Martinez, Juan F, et al.
Publicado: (2022)

Medication tendencies for inducing severe ocular surface symptoms in Japanese Stevens-Johnson Syndrome / toxic epidermal necrolysis patients
por: Saito, Yoshiro, et al.
Publicado: (2014)

Acute and Chronic Management of Ocular Disease in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis in the USA
por: Metcalfe, Derek, et al.
Publicado: (2021)

Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in India
por: Shanbhag, Swapna S., et al.
Publicado: (2021)

Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in Brazil
por: Wakamatsu, Tais Hitomi, et al.
Publicado: (2021)

Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan
por: Ma, David Hui-Kang, et al.
Publicado: (2021)

New insights in Stevens Johnson syndrome/ toxic epidermal necrolysis syndrome
por: Schroeder, Jan, et al.
Publicado: (2014)

Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Cheng, Lin
Publicado: (2021)

Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome
por: Ameen, Kaderthambi Hajamohideen Nooru, et al.
Publicado: (2013)

Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective
por: Thong, Bernard Yu-Hor
Publicado: (2013)

Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
por: Maciejewska, Jolanta, et al.
Publicado: (2014)

The role of malignancy in the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis
por: Wu, Jennifer, et al.
Publicado: (2014)

Ibuprofen induced Stevens-Johnson syndrome - toxic epidermal necrolysis in Nepal
por: Angadi, Siddheshwar S, et al.
Publicado: (2016)

Corrigendum to “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China”
por: Yang, Shang-Chen, et al.
Publicado: (2018)

Topical moxifloxacin-induced toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Dhavaleshwar, A, et al.
Publicado: (2019)

Study of Ocular Manifestations of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Abrol, Arundha, et al.
Publicado: (2020)

Allopurinol: Stevens Johnson syndrome/toxic epidermal necrolysis: case report
Publicado: (2022)

Study of genital manifestations of Stevens Johnson Syndrome/Toxic Epidermal Necrolysis
por: Gulanikar, Anirudha, et al.
Publicado: (2022)

Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in South Korea
por: Kim, Mee Kum, et al.
Publicado: (2021)

HLA association with antipyretic analgesics-induced Stevens-Johnson Syndrome / toxic epidermal necrolysis with severe ocular surface complications in japanese patients
por: Nakamura, Ryosuke, et al.
Publicado: (2014)

Phenytoin-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap in Focus: A Case Report
por: Puri, Piyush, et al.
Publicado: (2023)

Disease severity and status in Stevens–Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs
por: Lehloenya, Rannakoe J.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_97qq25o93439mgu8m91k33528r